On 18 December 2009 the Federal Joint Committee commissioned a supplementary commission for this report: "Cholinesterase inhibitors in Alzheimer's disease - supplementary commission: rivastigmine patches and galantamine (A09-05).
On 20 August 2009 the Federal Joint Committee commissioned an update search on this report: "Cholinesterase inhibitors in the treatment of Alzheimer's disease (A09-03).
Executive summary (PDF, 51 KB)
Final report (PDF, 1.1 MB)(date of translation: 26.09.2007)
completion 07.02.2007
published 10.04.2007 (German Version)
Preliminary report (PDF, 2.2 MB) (German version)
completion 01.09.2006
published 08.09.2006
The deadline for submission of comments on the preliminary report for commission A05-19A was 06.10.2006.
Amendment to the report plan (PDF, 36 KB) (German version)
completion 12.06.2006
published 20.06.2006
Report plan (PDF, 82 KB) (German version)
completion 02.06.2005
published 12.07.2005
The commission was awarded by the Federal Joint Committee on 22.02.2005.
